Form 4: Parker-Hannifin CFO Granted 7,878 Stock Appreciation Rights

Parker-Hannifin's EVP & CFO, Todd M. Leombruno, was granted 7,878 Stock Appreciation Rights with an exercise price of $742.97, vesting over three years.

Summary

• EVP & CFO Todd M. Leombruno of Parker-Hannifin Corp (PH) was granted 7,878 Stock Appreciation Rights (SARs).
• The SARs have an exercise price of $742.97 per share.
• The grant date for these SARs is August 20, 2025.
• These SARs will vest in three equal annual installments, starting on August 20, 2026.
• The expiration date for these SARs is August 19, 2035.
• Following this transaction, Mr. Leombruno beneficially owns 7,878 SARs directly.

Sentiment

Score: 7

Explanation: The grant of equity incentives to a key executive is generally a positive signal, aligning management's interests with shareholders. It's a standard practice, hence not extremely high, but certainly not negative.

Positives

• The grant of Stock Appreciation Rights aligns management's interests with shareholder value creation, as SARs gain value only if the stock price increases above the exercise price.
• The long vesting schedule (three years) and expiration date (2035) indicate a long-term incentive for the CFO, promoting retention and sustained performance.

Negatives

• No immediate cash inflow for the executive, as SARs are a future-oriented incentive whose value is realized only upon exercise and stock price appreciation.
• Potential for minor dilution if the SARs are exercised and settled in shares, as the underlying security is Common Stock.

Risks

• The value of the SARs is directly tied to the future performance of Parker-Hannifin's stock price; if the stock price does not exceed $742.97, the SARs may expire worthless.
• Market volatility could impact the potential gains from these SARs, introducing uncertainty regarding their ultimate value.

Future Outlook

The grant of long-term equity incentives like Stock Appreciation Rights suggests a management focus on future stock price appreciation and long-term value creation for shareholders. The vesting schedule encourages executive retention and sustained performance over several years.

Industry Context

Equity grants, particularly Stock Appreciation Rights or stock options, are a common form of executive compensation across various industries, including manufacturing and industrial sectors like Parker-Hannifin. They are designed to align executive incentives with shareholder returns and promote long-term strategic decision-making.

Comparison to Industry Standards

• The use of Stock Appreciation Rights (SARs) as a long-term incentive is a standard practice in executive compensation packages across industrial companies, similar to peers like Honeywell (HON) or Eaton (ETN).
• The vesting schedule of three equal annual installments is typical for such grants, promoting executive retention and long-term performance alignment.
• The exercise price being set at the market price on the grant date (implied by the nature of SARs and options) is also standard practice for aligning incentives with future stock performance.

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive incentives with shareholder value creation, as the SARs gain value only if the stock price appreciates. Potential for minor dilution if SARs are settled in shares.
• Management: The CFO receives a significant long-term incentive, potentially increasing retention and motivation to drive stock price growth.

Next Steps

• The SARs will begin vesting in three equal annual installments starting August 20, 2026.
• The executive will be able to exercise the vested SARs at any point before their expiration on August 19, 2035, provided the stock price is above the exercise price.

Key Dates

Recommendation

This filing reports a routine grant of Stock Appreciation Rights to a key executive, which is a standard component of executive compensation designed to align management incentives with long-term shareholder value. It does not present new information that would fundamentally alter the investment thesis for Parker-Hannifin, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Parker-Hannifin, PH, Stock Appreciation Rights, SARs, Executive Compensation, Insider Transaction, Todd M. Leombruno, CFO, Equity Grant